Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Gilliam Joseph EPRESIDENT & COO |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $230K 1,798 sh | Jan 26, 2026 |
| 3 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 46 | Kushel J. RichardSenior Managing Director |  BLKBlackRock, Inc.Open-market sale | SELL | $22.50M 20.0K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 45 | Carr James McgregorExecutive Vice Pres. |  CMACOMERICA INCOpen-market sale | SELL | $981K 10.0K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 45 | Weber James HarryExecutive Vice President | CMACOMERICA INC Open-market sale | SELL | $863K 8,798 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 44 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.03M 10.8K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 44 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $8.12M 87.3K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 44 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4.93M 52.6K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 42 | Howe JolandaSVP, GLOBAL CONTROLLER |  MIRMMirum Pharmaceuticals, Inc.Open-market sale | SELL | $86K 926 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 40 | Woodruff Ronald GreerEVP Safety, ESG, Maintenance |  JBHTHUNT J B TRANSPORT SERVICES INCOpen-market sale | SELL | $288K 1,391 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 38 | Quan JoanneCHIEF MEDICAL OFFICER | MIRMMirum Pharmaceuticals, Inc. Open-market sale | SELL | $170K 1,822 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 38 | Radovich PeterPRESIDENT AND COO | MIRMMirum Pharmaceuticals, Inc. Open-market sale | SELL | $222K 2,382 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 36 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.99M 33.3K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 36 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.02M 23.0K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 36 | Gadde VijayaDirector |  PLPlanet Labs PBCOpen-market sale | SELL | $535K 20.0K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 36 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.75M 19.3K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 36 | Hicks Bradley W.President of DCS | JBHTHUNT J B TRANSPORT SERVICES INC Open-market sale | SELL | $824K 3,919 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 36 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.39M 26.8K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 36 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.54M 27.6K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 35 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $48K 500 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 34 | Stefan Constantin IonelChief Technology Officer |  AMPXAmprius Technologies, Inc.Open-market sale | SELL | $5.93M 492.8K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 27 | Stefan Constantin IonelChief Technology Officer | AMPXAmprius Technologies, Inc. Open-market sale | SELL | $879K 73.3K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 26 | Edris BadreddinDirector |  EWTXEdgewise Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.96M 66.5K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 26 | Schreiber Daniel A.Director, Chief Executive Officer |  LMNDLemonade, Inc.Open-market sale · 10b5-1 plan | SELL | $12.00M 126.6K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 26 | Qatanani MoCHIEF SCIENTIFIC OFFICER |  SRRKScholar Rock Holding CorpOpen-market sale · 10b5-1 plan | SELL | $599K 12.8K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 22 | Coyne Terrance P.EVP & CFO |  RPRXRoyalty Pharma plcOpen-market sale · 10b5-1 plan | SELL | $2.59M 65.8K sh | Jan 23, 2026 traded Jan 20, 2026 |
| 21 | Roberts ZacharyEVP of R&D |  ALLOAllogene Therapeutics, Inc.Open-market sale | SELL | $41K 26.3K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 20 | Stout Jay SChief Technology Officer |  IMVTImmunovant, Inc.Open-market sale | SELL | $51K 1,977 sh | Jan 23, 2026 traded Jan 21, 2026 |
| 19 | Qatanani MoCHIEF SCIENTIFIC OFFICER | SRRKScholar Rock Holding Corp Open-market sale · 10b5-1 plan | SELL | $97K 2,119 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 17 | Stefan Constantin IonelChief Technology Officer | AMPXAmprius Technologies, Inc. Open-market sale | SELL | $19K 1,600 sh | Jan 23, 2026 traded Jan 23, 2026 |
| 17 | Ugwumba Chidozie10% Owner |  CLNNClene Inc.Open-market sale | SELL | $67K 12.7K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 16 | Peters John SheldonChief Insurance Officer | LMNDLemonade, Inc. Open-market sale · 10b5-1 plan | SELL | $810K 9,000 sh | Jan 23, 2026 traded Jan 22, 2026 |
| 16 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $148K 3,750 sh | Jan 23, 2026 traded Jan 20, 2026 |
| 15 | Edris BadreddinDirector | EWTXEdgewise Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $308K 10.5K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 15 | Edris BadreddinDirector | EWTXEdgewise Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $507K 17.2K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 15 | O'Melia Scott L.Chief Legal Officer |  DRVNDriven Brands Holdings Inc.Open-market sale · 10b5-1 plan | SELL | $750K 46.9K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 15 | Reagan Ronald REVP, Eng., Const. & ISC |  NEENEXTERA ENERGY INCOpen-market sale · 10b5-1 plan | SELL | $920K 10.8K sh | Jan 23, 2026 traded Jan 22, 2026 |
| 15 | Edris BadreddinDirector | EWTXEdgewise Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $403K 13.7K sh | Jan 23, 2026 traded Jan 21, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $29K 5,556 sh | Jan 23, 2026 traded Jan 23, 2026 |